emerging immunotherapy options for metastatic nsclc
Published 6 years ago • 205 plays • Length 7:27Download video MP4
Download video MP3
Similar videos
-
3:46
emerging immunotherapies and combinations for nsclc
-
4:02
immunotherapy options for lung cancer variations
-
0:41
treatment options for metastatic non-small cell lung cancer with no actionable mutations in 1l
-
4:27
emerging treatment options for sclc
-
1:06
improving outcomes for patients with metastatic nsclc with immunotherapy
-
5:03
immunotherapy in metastatic nsclc
-
4:55
emerging therapies for nonsquamous nsclc
-
1:33
the emerging role of localized therapy in metastatic nsclc
-
1:48
dr. mark kris on immunotherapy and frontline options for patients with nsclc
-
1:09
sarah b. goldberg discusses new immunotherapy options for patients with lung cancer
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
5:43
duration of upfront immunotherapy for nsclc
-
1:31
dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:00:09
new options for lung cancer therapies
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
47:52
introducing novel immunotherapeutic approaches for metastatic nsclc without driver mutations
-
7:10
the role of immunotherapy in metastatic nsclc
-
9:18
gracecast - treatment options for metastatic nsclc
-
7:39
immunotherapy paradigm for newly diagnosed nsclc